According to FutureWise analysis the Stent Delivery Systems Market in 2025 is US$ 11.46 billion, and is expected to reach US$ 22.78 billion by 2033 at a CAGR of 8.97%. The growth is fueled by the rising prevalence of cardiovascular diseases, advancements in minimally invasive procedures, and the increased use of drug-eluting and bioresorbable stents. Innovations in stent delivery technology and improved imaging guidance are also enhancing procedural success rates and patient outcomes.
Stents are placed in the body to open or to give support to the organ and delivery through this stent makes a very easy way to administer a drug or correct the abnormality in the organ. Nowadays, stent delivery systems are usually designed for through-the-scope (TTS) deployment, whereas some SEMS (self-expandable metallic stents) designs are delivered over a guide wire using fluoroscopy, also referred to as over-the-wire (OTW). With OTW delivery systems, the endoscopist can also reintroduce the endoscope alongside the stent delivery system for an endoscopic view during SEMS deployment. Most systems also allow for recapture and repositioning of the SEMS until a certain “point of no return” has been reached.
Stent delivery system offers precise and intuitive deployment of the stent during a medical intervention. It reduces medical errors and improves patient compliance during the stenting process. Increasing demand of delivery systems in healthcare settings led to the robust growth of the market. Along with this, growing research activities has shown delivery systems are more reliable and easy to use than traditional methods. Further, government bodies are more focused on offering sustained healthcare services to minimize the cost burden. It led to the rapid development of special delivery systems to minimize the complications and to improve the patient outcome. It indirectly led to the potential growth of the market. Further, growing technologies have fuelled the development process of delivery systems during the forecast period.
Fourth-Generation Drug-Eluting Stents (DES): The latest drug-eluting stent technologies feature polymer-free designs, bioresorbable scaffolds, and nanotechnology-enhanced drug delivery systems. These innovations aim to improve long-term outcomes by promoting natural vessel healing, restoring vasomotion, and eliminating permanent metallic implants.